Haematological cancer: Anti-PD-1 therapy with nivolumab after allo-HSCT for Hodgkin lymphoma.
Nat Rev Clin Oncol. 2017 Mar 29;:
Authors: Killock D
PMID: 28352133 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου